补阳还五汤有效成分降血脂作用研究进展
Research Progress in Effect of Buyang Huanwu Decoction Active Components for Lowering Blood Lipid
DOI: 10.12677/TCM.2023.1212534, PDF,    国家自然科学基金支持
作者: 方诗剑, 马玉雪, 杨帅虎, 杨蕊红, 牛雯颖*：黑龙江中医药大学研究生院，黑龙江 哈尔滨
关键词: 补阳还五汤；高脂血症；降脂作用；研究进展；Buyang Huanwu Decoction； Hyperlipoidemia； The Ability to Reduce Blood Lipid； Research Progress
摘要: 随着人民生活水平的日益提高，血脂水平和血脂异常患病率也显著升高，血脂异常通常与高血压、冠心病等基础疾病密切相关。补阳还五汤作为治疗脑卒中和冠心病的经典方剂，在实验研究中常显示出纠正实验动物血脂异常的能力，其有效成分有黄芪甲苷、芍药苷、芍药内酯苷、苦杏仁苷、阿魏酸和山柰酚、异鼠李素、槲皮素等。本文通过查阅国内外文献，对补阳还五汤中存在降血脂能力的成分进行综述。
Abstract: With the improvement of people’s living standard, the level of blood lipids and the prevalence of dyslipidemia are also significantly increased. Dyslipidemia is usually closely related to basic dis-eases such as hypertension and coronary atherosclerotic heart disease. As a classical prescription for the treatment of cerebral stroke and coronary atherosclerotic heart disease, Buyang Huanwu Decoction (BHD) often shows the ability to correct dyslipidemia in animals in studies. BHD’s active ingredients include astragaloside IV, paeoniflorin, albiflorin, amygdalin, ferulic acid, kaempferol, isorhamnetin, quercetin and so on. In this paper, the constituents of BHD with the ability to reduce blood lipid were reviewed by referring to domestic and foreign literatures.
文章引用：方诗剑, 马玉雪, 杨帅虎, 杨蕊红, 牛雯颖. 补阳还五汤有效成分降血脂作用研究进展[J]. 中医学, 2023, 12(12): 3587-3596. https://doi.org/10.12677/TCM.2023.1212534

参考文献

[1] 赵冬. 中国人群血脂异常流行趋势和治疗控制现状[J]. 中华心血管病杂志, 2019(5): 341-343.
[2] NCD Risk Factor Collaboration (NCD-RisC) (2020) Repositioning of the Global Epicentre of Non-Optimal Cholesterol. Nature, 582, 73-77.
[3] 陈玉梅, 江昌铭. 常用降脂中药的研究进展[J]. 光明中医, 2022, 37(9): 1689-1692.
[4] 周小玲, 杜艳华, 陈晓辉, 等. 补阳还五汤联合阿托伐他汀治疗冠心病心绞痛的临床研究[J]. 中西医结合心脑血管病杂志, 2020, 18(4): 650-652.
[5] 苏亚楠. 中西医结合治疗冠心病气虚血瘀型临床观察[J]. 实用中医药杂志, 2021, 37(6): 963-964.
[6] 陈思羽, 袁前发, 王颖, 等. 黄芪多糖对高脂血症大鼠糖脂代谢及胰腺组织病理改变的影响[J]. 广东药科大学学报, 2018, 34(4): 457-461.
[7] 刘坚. 黄芪多糖通过AMPK介导的AS160磷酸化刺激葡萄糖摄取的机制研究[D]: [博士学位论文]. 武汉: 武汉大学, 2012.
[8] 冯作化, 药立波. 生物化学与分子生物学[M]. 北京: 人民卫生出版社, 2015: 306
[9] Wang, K., Tang, Z., Zheng, Z., et al. (2016) Protective Effects of Angelica sinensis Polysaccharide against Hyperglycemia and Liver Injury in Multiple Low-Dose Streptozotocin-Induced Type 2 Diabetic BALB/c Mice. Food & Function, 7, 4889-4897. [Google Scholar] [CrossRef] 
[10] 孟祥云, 张之弘, 汪永锋, 等. 当归多糖对糖尿病大鼠脂代谢及脂肪因子的影响[J]. 西部中医药, 2021, 34(11): 33-36.
[11] 曹鹏, 张玉, 汪汉香, 等. 当归多糖对小鼠急性酒精性肝病的预防作用及对HIF-1α蛋白的影响[J]. 中华中医药杂志, 2021, 36(6): 3628-3631.
[12] 刘瑾, 张洁, 冯莹. 苦杏仁苷减少冠状动脉内皮细胞焦亡并改善载脂蛋白E缺陷小鼠动脉粥样硬化斑块形成[J]. 实用医学杂志, 2023, 39(14): 1746-1755.
[13] Lv, J.Z., Xiong, W., Lei, T.T., et al. (2017) Amygdalin Ameliorates the Progression of Atherosclerosis in LDL Receptor-Deficient Mice. Molecular Medicine Reports, 16, 8171-8179. [Google Scholar] [CrossRef] [PubMed]
[14] Moslehi, A., Farahabadi, M., Chavoshzadeh, S.A., et al. (2018) The Effect of Amygdalin on Endoplasmic Reticulum (ER) Stress Induced Hepatic Steatosis in Mice. Malaysian Journal of Medical Sciences, 25, 16-23. [Google Scholar] [CrossRef] [PubMed]
[15] Ma, Z.H., Chu, L., Liu, H.Y., et al. (2017) Beneficial Effects of Paeoniflorin on Non-Alcoholic Fatty Liver Disease Induced by High-Fat Diet in Rats. Scientific Reports, 7, Article No. 44819.
[16] Zhang, L.J., Yang, B. and Yu, B.P. (2015) Paeoniflorin Protects against Nonalcoholic Fatty Liver Disease Induced by a High-Fat Diet in Mice. Biological and Pharmaceutical Bulletin, 38, 1005-1011. [Google Scholar] [CrossRef] [PubMed]
[17] Ma, Z.H., Chu, L., Liu, H.Y., et al. (2016) Paeoniflorin Alleviates Non-Alcoholic Steatohepatitis in Rats: Involvement with the ROCK/NF-κB Pathway. International Immunopharmacol-ogy, 38, 377-384. [Google Scholar] [CrossRef] [PubMed]
[18] 孙继友. 芍药内酯苷对泡沫细胞及动脉粥样硬化形成的影响[D]: [博士学位论文]. 长春: 吉林大学, 2017
[19] Zhou, X., Fouda, S., Zeng, X.Y., et al. (2019) Characterization of the Therapeutic Profile of Albiflorin for the Metabolic Syndrome. Frontiers in Pharmacology, 10, Article No. 1151. [Google Scholar] [CrossRef] [PubMed]
[20] 张伟娇, 谭梅傲, 柯雪红, 等. 芪葛汤有效成分降脂的体外初筛实验[J]. 广州中医药大学学报, 2021, 38(8): 1700-1707.
[21] Luo, Z.X., Wang, Y.Q., Xue, M.Z., et al. (2021) Astragaloside IV Ameliorates fat Metabolism in the Liver of Ageing Mice through Targeting Mitochondrial Activity. Journal of Cellular and Molecular Medicine, 25, 8863-8876. [Google Scholar] [CrossRef] [PubMed]
[22] Wu, H., Gao, Y., Shi, H.L., et al. (2016) Astragaloside IV Improves Li-pid Metabolism in Obese Mice by Alleviation of Leptin Resistance and Regulation of Thermogenic Network. Scientific Reports, 6, Article No. 30190. [Google Scholar] [CrossRef] [PubMed]
[23] Qin, H.W., Liu, P. and Lin, S.C. (2015) Effects of Astragaloside IV on the SDF-1/CXCR4 Expression in Atherosclerosis of apoE(-/-) Mice Induced by Hyperlipaemia. Evidence-Based Comple-mentary and Alternative Medicine, 2015, Article ID: 385154. [Google Scholar] [CrossRef] [PubMed]
[24] Kumar, S., Prahalathan, P., Saravanakumar, M., et al. (2014) Vanillic Acid Prevents the Deregulation of Lipid Metabolism, Endo-thelin 1 and up Regulation of Endothelial Nitric Oxide Synthase in Nitric Oxide Deficient Hypertensive Rats. European Journal of Pharmacology, 743, 117-125. [Google Scholar] [CrossRef] [PubMed]
[25] 陈倩, 伊力亚斯∙艾萨, 雷秀英, 等. 香草酸通过诱导自噬缓解HepG2细胞脂肪变性[J]. 中国临床药理学杂志, 2021, 37(19): 2622-2626.
[26] 徐冲, 何金汗, 徐国恒. 脂滴包被蛋白(perilipin)调控脂肪分解[J]. 生理科学进展, 2006, 37(3): 221-224.
[27] Bumrungpert, A., Lilitchan, S., Tuntipopipat, S., et al. (2018) Ferulic Acid Supplementation Improves Li-pid Profiles, Oxidative Stress, and Inflammatory Status in Hyperlipidemic Subjects: A Randomized, Double-Blind, Pla-cebo-Controlled Clinical Trial. Nutrients, 10, Article No. 713. [Google Scholar] [CrossRef] [PubMed]
[28] 陈阜新, 汪莲开. 阿魏酸对巨噬细胞泡沫样化过程中胆固醇流出的影响及可能机制[J]. 中国中药杂志, 2015, 40(3): 533-537.
[29] 熊鸣, 毕勇毅, 张德玲, 等. 阿魏酸钠对高脂血症致动脉粥样硬化过程中胆固醇和甘油三酯代谢的影响[J]. 中国病理生理杂志, 2008, 24(9): 1670-1675.
[30] 饶文婷, 罗尚菲, 张雅心, 等. 阿魏酸对高脂血症小鼠肝脂肪变性及肠道菌群的调节作用[J]. 中国实验动物学报, 2020, 28(1): 36-42.
[31] 史海燕, 郗艳丽. 没食子酸生物活性研究进展[J]. 吉林医药学院学报, 2020, 41(2): 146-149.
[32] Paraíso, A.F., Sousa, J.N., Andrade, J.M.O., et al. (2019) Oral Gallic Acid Improves Metabolic Profile by Modulating SIRT1 Expression in Obese Mice Brown Adipose Tissue: A Molecular and Bioinformatic Approach. Life Sciences, 237, Article ID: 116914. [Google Scholar] [CrossRef] [PubMed]
[33] 王绍梅, 李晓君, 宋文明, 等. 普洱茶中没食子酸及其改善饮食诱导的糖脂代谢紊乱研究进展[J]. 茶叶科学, 2020, 40(4): 431-440.
[34] Zeng, X.Q., Sheng, Z.T., Li, X.X., et al. (2019) In Vitro Studies on the Interactions of Blood Lipid Level-Related Biological Molecules with Gallic Acid and Tan-nic Acid. Journal of the Science of Food and Agriculture, 99, 6882-6892. [Google Scholar] [CrossRef] [PubMed]
[35] 幸奠霞, 刘志高, 薛存宽, 等. 刺芒柄花素雌激素样作用及其与血脂相关性研究[J]. 中国老年学杂志, 2009, 29(18): 2340-2342.
[36] 陶金, 陶磊, 黄文华. 刺芒柄花素通过促进解偶联蛋白1(UCP1)表达刺激棕色脂肪细胞产热[J]. 细胞与分子免疫学杂志, 2020, 36(3): 242-247.
[37] 赵培, 杨媛, 徐扬, 等. 刺芒柄花素调节血脂代谢及改善动脉粥样硬化病变的实验研究[J]. 中国新药杂志, 2009, 18(10): 925-929.
[38] Ma, C.R., Xia, R.L., Yang, S., et al. (2020) Formononetin Attenuates Atherosclerosis via Regulating In-teraction between KLF4 and SRA in apoE-/- Mice. Theranostics, 10, 1090-1106. [Google Scholar] [CrossRef] [PubMed]
[39] 张华敏, 刘娜, 邓巧娟. 羟基红花黄色素A对非酒精性脂肪肝炎细胞的作用[J]. 中医药导报, 2021, 27(3): 9-12+22.
[40] Lee, M.S., Li, H.L., Zhao, H.X., et al. (2020) Effects of Hy-droxysafflor Yellow A on the PI3K/AKT Pathway and Apoptosis of Pancreatic β-Cells in Type 2 Diabetes Mellitus Rats. Diabetes, Metabolic Syndrome and Obesity, 13, 1097-1107. [Google Scholar] [CrossRef] 
[41] 柴文, 付龙生, 吕燕妮. 羟基红花黄色素A对高脂血症脂肪肝大鼠肝脏功能的干预作用[J]. 江西医药, 2018, 53(1): 18-21.
[42] 魏紫奕, 徐文娟, 董姣姣, 等. 羟基红花黄色素A对动脉粥样硬化早期脂肪酸的调控研究[J]. 药学学报, 2018, 53(10): 1680-1688.
[43] 张冬青, 王海宝, 王淑芳, 等. 毛蕊异黄酮生物活性的研究进展[J]. 中国中药杂志, 2015, 40(22): 4339-4345.
[44] 刘丽, 林庶如, 李军, 等. 毛蕊异黄酮葡萄糖苷与葛根素及其配伍对3T3-L1前脂肪细胞胰岛素抵抗细胞模型的影响[J]. 中药药理与临床, 2018, 34(1): 10-14.
[45] 侯瑞英, 吴冬梅, 焦伟杰, 等. 毛蕊异黄酮改善2型糖尿病模型大鼠的糖脂代谢紊乱和代谢相关脂肪性肝病症状[J]. 中国病理生理杂志, 2021, 37(11): 1965-1971.
[46] 李博文, 赵亮, 王勇, 等. 槲皮素、山柰酚和芦丁对高果糖和高脂饮食诱导的大鼠代谢综合征的影响[J]. 食品科学, 2019, 40(17): 223-233.
[47] Kobori, M., Masumoto, S., Akimoto, Y., et al. (2011) Chronic Dietary Intake of Quercetin Alleviates Hepatic Fat Accumulation Associated with Consumption of a Western-Style Diet in C57/BL6J Mice. Molecular Nutrition & Food Research, 55, 530-540. [Google Scholar] [CrossRef] [PubMed]
[48] Jeong, S.M., Kang, M.J., Choi, H.N., et al. (2012) Quercetin Ame-liorates Hyperglycemia and Dyslipidemia and Improves Antioxidant Status in Type 2 Diabetic db/db Mice. Nutrition Re-search and Practice, 6, 201-207. [Google Scholar] [CrossRef] [PubMed]
[49] 孔令希. 山奈酚抗动脉粥样硬化作用机理探讨及其药代动力学研究[D]: [硕士学位论文]. 重庆: 重庆医科大学, 2014.
[50] 李秀英. 丹皮酚和山奈酚抑制巨噬细胞泡沫化机制的比较研究[D]: [博士学位论文]. 重庆: 重庆医科大学, 2014.
[51] 吴巧敏, 倪海祥, 卢笑, 等. 山奈酚延缓自发性肥胖2型糖尿病小鼠肾损伤研究[J]. 心脑血管病防治, 2017, 17(1): 19-22.
[52] 杨胜楠. 山奈酚-3-O-葡萄糖醛酸苷、黄芩苷调节糖代谢的作用机制研究[D]: [硕士学位论文]. 天津: 南开大学, 2019.
[53] Rodríguez-Rodríguez, C., Torres, N., Gutiérrez-Uribe, J.A., et al. (2015) The Effect of Isorhamnetin Glycosides Extracted from Opuntia fi-cus-indica in a Mouse Model of Diet Induced Obesity. Food & Function, 6, 805-815. [Google Scholar] [CrossRef] 
[54] Zhang, Y., Gu, M., Cai, W.J., et al. (2016) Dietary Component Iso-rhamnetin Is a PPARγ Antagonist and Ameliorates Metabolic Disorders Induced by Diet or Leptin Deficiency. Scientific Reports, 6, Article No. 19288. [Google Scholar] [CrossRef] [PubMed]
[55] Ressaissi, A., Attia, N., Falé, P.L., et al. (2017) Isorhamnetin Derivatives and Piscidic Acid for Hypercholesterolemia: Cholesterol Permeability, HMG-CoA Reductase Inhibition, and Docking Studies. Archives of Pharmacal Research, 40, 1278-1286. [Google Scholar] [CrossRef] [PubMed]
[56] 周健, 杜凤, 康秉文, 等. 异鼠李素通过减轻氧化应激改善游离脂肪酸诱导肝细胞脂质沉积[J]. 中南药学, 2021, 19(3): 376-381.
[57] 王婷婷, 李妍, 张明明, 等. 异鼠李素通过抑制泡沫细胞形成增加动脉粥样硬化斑块稳定性的机制研究[J]. 实用心脑肺血管病杂志, 2022, 30(2): 69-74.
[58] 王俊博. 五种黄酮成分对脂肪堆积HepG2细胞脂质代谢的影响和机制初探[D]: [硕士学位论文]. 广州: 广州中医药大学, 2019.
[59] 古送汗∙买提尼亚孜, 陈悦, 尚佳, 等. 微小RNA在槲皮素改善高脂膳食小鼠肝脏脂肪变性中的作用[J]. 营养学报, 2021, 43(6): 584-590.
[60] Cui, Y.J., Hou, P.B., Li, F.H., et al. (2017) Quercetin Improves Macrophage Reverse Cholesterol Transport in Apolipoprotein E-Deficient Mice Fed a High-Fat Diet. Lipids in Health and Disease, 16, 9. [Google Scholar] [CrossRef] [PubMed]
[61] Lee, S.M., Moon, J.Y., Cho, Y., et al. (2013) Quercetin Up-Regulates Expressions of Peroxisome Proliferator-Activated Receptor γ, Liver X Receptor α, and ATP Binding Cas-sette Transporter A1 Genes and Increases Cholesterol Efflux in Human Macrophage Cell Line. Nutrition Research, 33, 136-143. [Google Scholar] [CrossRef] [PubMed]
[62] Chang, Y.C., Lee, T.S. and Chiang, A.N. (2012) Quercetin En-hances ABCA1 Expression and Cholesterol Efflux through a p38-Dependent Pathway in Macrophages. Journal of Lipid Research, 53, 1840-1850. [Google Scholar] [CrossRef] 
[63] Lee, W., Koo, H.R., Choi, Y.J., et al. (2019) Z-Ligustilide and n-Butylidenephthalide Isolated from the Aerial Parts of Angelica tenuissima Inhibit Lipid Accumulation in Vitro and in Vivo. Planta Medica, 85, 719-728. [Google Scholar] [CrossRef] [PubMed]
[64] 陈琼, 黄水清. 黄芪总皂苷、当归挥发油对动脉粥样硬化ApoE-/-小鼠脂质代谢的影响[J]. 中药新药与临床药理, 2021, 32(6): 791-798.
[65] Lu, K.Y., Dass, K.T.P., Lin, S.Z., et al. (2021) N-Butylidenephthalide Ameliorates High-Fat Diet-Induced Obesity in Mice and Promotes Browning through Adrenergic Response/AMPK Activation in Mouse Beige Adipocytes. Biochimica et Biophysica Acta: Molecular and Cell Biology of Lipids, 1866, Article ID: 159033. [Google Scholar] [CrossRef] [PubMed]
[66] Desai, A.J., Dong, M.Q. and Miller, L.J. (2016) Beneficial Ef-fects of β-Sitosterol on Type 1 Cholecystokinin Receptor Dysfunction Induced by Elevated Membrane Cholesterol. Clin-ical Nutrition, 35, 1374-1379. [Google Scholar] [CrossRef] [PubMed]
[67] Calpe-Berdiel, L., Escolà-Gil, J.C. and Blanco-Vaca, F. (2009) New Insights into the Molecular Actions of Plant Sterols and Stanols in Cholesterol Metabolism. Atherosclerosis, 203, 18-31. [Google Scholar] [CrossRef] [PubMed]
[68] Feng, S.M., Dai, Z.Q., Liu, A.B., et al. (2018) Intake of Stigmasterol and β-Sitosterol Alters Lipid Metabolism and Alleviates NAFLD in Mice Fed a High-Fat Western-Style Di-et. Biochimica et Biophysica Acta: Molecular and Cell Biology of Lipids, 1863, 1274-1284. [Google Scholar] [CrossRef] [PubMed]
[69] Zhao, J.F., Jim Leu, S.J., Shyue, S.K., et al. (2013) Novel Effect of Paeonol on the Formation of Foam Cells: Promotion of LXRα-ABCA1-Dependent Cholesterol Efflux in Macrophages. The American Journal of Chinese Medicine, 41, 1079-1096. [Google Scholar] [CrossRef] 
[70] Li, X.Y., Zhou, Y.D., Yu, C., et al. (2015) Paeonol Suppresses Lipid Accumulation in Macrophages via Upregulation of the ATP-Binding Cassette Transporter A1 and Downregulation of the Cluster of Differentiation 36. International Journal of Oncology, 46, 764-774. [Google Scholar] [CrossRef] [PubMed]
[71] 牛文贵, 张红珍. 川芎嗪对动脉粥样硬化模型血脂的影响[J]. 现代中医药, 2012, 32(6): 67-69.
[72] Chen, J.C., Tian, J.J., Ge, H.F., et al. (2017) Effects of Tet-ramethylpyrazine from Chinese Black Vinegar on Antioxidant and Hypolipidemia Activities in HepG2 Cells. Food and Chemical Toxicology, 109, 930-940. [Google Scholar] [CrossRef] [PubMed]
[73] Duan, J., Xiang, D., Luo, H.L., et al. (2017) Tetramethylpyrazine Suppresses Lipid Accumulation in Macrophages via Upregulation of the ATP-Binding Cassette Transporters and Down-regulation of Scavenger Receptors. Oncology Reports, 38, 2267-2276. [Google Scholar] [CrossRef] [PubMed]